Sukhi Jagpal Insider Profile
4 Followers
Sukhi Jagpal, Director at Sutro Biopharma, holds ― shares in Sutro Biopharma (Ticker: STRO), holds 1.20K shares in Novelion Therapeutics (Ticker: NVLNF), holds ― shares in Sierra Oncology (Ticker: SRRA).
Sukhi Jagpal's Trading History
| NVLNFNovelion Therapeutics | May 14, 2013 | ― | Informative Sell | 79.50K | $842.40 | |
| SRRASierra Oncology | ― | ― | ― | ― | ||
| STROSutro Biopharma | ― | Director | ― | ― |
You May Also Like
Sukhi Jagpal insider profile FAQ
What is the percentage of profitable transactions made by Sukhi Jagpal?
The percentage of profitable transactions made by Sukhi Jagpal is 0%.
What is the average return per transaction made by Sukhi Jagpal?
The average return per transaction made by Sukhi Jagpal is -9.20%.
What stocks does Sukhi Jagpal hold?
Sukhi Jagpal holds: STRO, NVLNF, SRRA stocks.
What was Sukhi Jagpal's most profitable transaction?
Sukhi Jagpal’s most profitable transaction was an Informative Sell of NVLNF stock on August 7, 2012. The return on the trade was -1.30%.
What is Sukhi Jagpal's role in Sutro Biopharma?
Sukhi Jagpal's role in Sutro Biopharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
